153 related articles for article (PubMed ID: 14653214)
1. [Laboratory data for assessment of nutrition in liver disease--with special reference to alcoholic hepatitis and nonalcoholic steatohepatitis (NASH)].
Sugimoto M
Rinsho Byori; 2003 Oct; Suppl 127():45-51. PubMed ID: 14653214
[No Abstract] [Full Text] [Related]
2. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
3. Keratin-18 as a marker of steatohepatitis.
Gonzalez-Quintela A; Lojo S; Otero E; Perez LF
Hepatology; 2007 Feb; 45(2):545. PubMed ID: 17256723
[No Abstract] [Full Text] [Related]
4. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins.
Bookman ID; Pham J; Guindi M; Heathcote EJ
Liver Int; 2006 Jun; 26(5):566-71. PubMed ID: 16762001
[TBL] [Abstract][Full Text] [Related]
5. Lecithin:cholesterol acyltransferase as a component of enzyme patterns in acute and chronic liver disease. A preliminary report.
Lautz HU; Schmidt E; Barthels M; Kiessler G
Scand J Clin Lab Invest Suppl; 1978; 150():183-6. PubMed ID: 746346
[No Abstract] [Full Text] [Related]
6. [Pathological and clinical analysis of nonalcoholic steatohepatitis].
Pan HY; Ye RX; Shi JP; Guo XF
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):384. PubMed ID: 12837234
[No Abstract] [Full Text] [Related]
7. [Non-cirrhotic alcoholic liver disease. Pathological anatomy, diagnosis, course, treatment].
Rueff PB
Rev Prat; 1996 Feb; 46(4):475-8. PubMed ID: 8729354
[No Abstract] [Full Text] [Related]
8. FibroMAX: towards a new universal biomarker of liver disease?
Morra R; Munteanu M; Imbert-Bismut F; Messous D; Ratziu V; Poynard T
Expert Rev Mol Diagn; 2007 Sep; 7(5):481-90. PubMed ID: 17892356
[TBL] [Abstract][Full Text] [Related]
9. [Chronic alcoholic and non-alcoholic steatohepatitis].
Tsimmerman IaS
Klin Med (Mosk); 2004; 82(7):9-14. PubMed ID: 15449765
[No Abstract] [Full Text] [Related]
10. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.
Chen C; Schmilovitz-Weiss H; Liu XE; Pappo O; Halpern M; Sulkes J; Braun M; Cohen M; Barak N; Tur-Kaspa R; Vanhooren V; Van Vlierberghe H; Libert C; Contreras R; Ben-Ari Z
J Proteome Res; 2009 Feb; 8(2):463-70. PubMed ID: 19140676
[TBL] [Abstract][Full Text] [Related]
11. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.
Palekar NA; Naus R; Larson SP; Ward J; Harrison SA
Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452
[TBL] [Abstract][Full Text] [Related]
12. The emerging problem of nonalcoholic steatohepatitis (NASH).
Portincasa P; Grattagliano I; Palmieri VO; Palasciano G
Rom J Gastroenterol; 2005 Mar; 14(1):43-51. PubMed ID: 15800693
[TBL] [Abstract][Full Text] [Related]
13. [Definition and management of non-alcoholic steatohepatitis (NASH)].
Hütteroth TH
Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S64-7. PubMed ID: 11450617
[No Abstract] [Full Text] [Related]
14. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.
Ahmed MH
Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631
[No Abstract] [Full Text] [Related]
15. Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH).
Sasaki N; Ueno T; Morita Y; Nagata E; Sata M
Hepatogastroenterology; 2006; 53(71):678-81. PubMed ID: 17086867
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Miele L; Forgione A; Gasbarrini G; Grieco A
Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic steatohepatitis.
Das K; Kar P
J Assoc Physicians India; 2005 Mar; 53():195-9. PubMed ID: 15926603
[TBL] [Abstract][Full Text] [Related]
18. Morphology of alcoholic liver disease.
Lefkowitch JH
Clin Liver Dis; 2005 Feb; 9(1):37-53. PubMed ID: 15763228
[TBL] [Abstract][Full Text] [Related]
19. The use of protein tyrosine phosphatase 1B and insulin receptor immunostains to differentiate nonalcoholic from alcoholic steatohepatitis in liver biopsy specimens.
Sanderson SO; Smyrk TC
Am J Clin Pathol; 2005 Apr; 123(4):503-9. PubMed ID: 15743753
[TBL] [Abstract][Full Text] [Related]
20. Steatohepatitis: comparison of alcoholic and non-alcoholic subjects with particular reference to portal hypertension and hepatic complications.
Crawford DH; Powell EE; Searle J; Powell LW
J Gastroenterol Hepatol; 1989; 4 Suppl 1():36-8. PubMed ID: 2519082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
